Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025
AbCellera and Eli Lilly to Co-Develop COVID-19 Therapeutic Antibodies Medical Countermeasures March 12, 2020 …
DARPA P3 Researchers Race to Create Treatment for the Novel Coronavirus Medical Countermeasures March 11, 2020 …
Critical Bioeconomy Asset in Need of Attention: BSL-3 and BSL-4 Laboratories in the U.S. Medical Countermeasures March 6, 2020 …
Passive Immunization with mAbs Against Aerosolized Ricin Toxin Medical Countermeasures March 6, 2020 …
Soligenix Announces Successful Demonstration of Heat Stabilization for Filovirus Vaccine Platform Medical Countermeasures March 3, 2020 …
CureVac CEO Discusses Coronavirus Vaccine Development with White House Leadership Medical Countermeasures March 3, 2020 …
Senator Markey Introduces Legislation to Invest $1 Billion in Universal Coronavirus Vaccine Medical Countermeasures March 2, 2020 …
Patients in Nebraska Part of First COVID-19 Clinical Trial in U.S. Medical Countermeasures February 25, 2020 …
University of Queensland COVID-19 Vaccine Goes Into Test Production Medical Countermeasures February 23, 2020 …
JLABS @ Washington DC Seeks Innovations for Pediatric Influenza Interventions Contracts + Grants February 22, 2020 …
Tulane National Primate Research Center Launches Coronavirus Research Program Medical Countermeasures February 21, 2020 …
Columbia University Researchers Awarded $2M to Identify Antiviral Drugs for Coronavirus Medical Countermeasures February 21, 2020 …
Columbia University Researchers Awarded $2 Million to Identify Antiviral Drugs for New Coronavirus Medical Countermeasures February 20, 2020 …
Synedgen to Present Data on Therapeutic for Ocular Mustard Gas Injury at NIH Meeting CBRNE February 19, 2020 …
Humanetics Corporation Acquires Manufacturing Assets for Radioprotectant Drug CBRNE February 19, 2020 …
NIH Study Supports New Approach for Treating Cerebral Malaria Infectious Diseases February 19, 2020 …
